In Vitro Activities of the Glycylcycline GAR-936 against Gram-Positive Bacteria

Authors:

Abstract
The in vitro activities of GAR-936, the 9- t -butylglycylamido derivative of minocycline, were compared with those of doxycycline, minocycline, and tetracycline against 527 gram-positive clinical isolates. GAR-936 inhibited all strains, including those resistant to other tetracyclines, at concentrations of ≤2 μg/ml, except two strains of JK diphtheroids for which the MIC was 4 μg/ml.

This publication has 15 references indexed in Scilit: